CRISPR Therapeutics AG (CRSP)
51.72
-0.54
(-1.03%)
USD |
NASDAQ |
Sep 11, 16:00
51.49
-0.23
(-0.44%)
After-Hours: 07:10
CRISPR Therapeutics Total Return Level : 51.72 for Sept. 11, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 11, 2026 | 51.72 |
| September 10, 2026 | 52.26 |
| September 09, 2026 | 53.45 |
| September 08, 2026 | 54.78 |
| September 04, 2026 | 55.79 |
| September 03, 2026 | 56.49 |
| September 02, 2026 | 56.92 |
| September 01, 2026 | 56.82 |
| August 31, 2026 | 56.98 |
| August 28, 2026 | 57.72 |
| August 27, 2026 | 59.37 |
| August 26, 2026 | 59.23 |
| August 25, 2026 | 60.90 |
| August 24, 2026 | 57.08 |
| August 21, 2026 | 59.50 |
| August 20, 2026 | 58.12 |
| August 19, 2026 | 59.81 |
| August 18, 2026 | 52.97 |
| August 17, 2026 | 54.28 |
| August 14, 2026 | 53.55 |
| August 13, 2026 | 53.99 |
| August 12, 2026 | 53.99 |
| August 11, 2026 | 54.07 |
| August 10, 2026 | 53.51 |
| August 07, 2026 | 53.52 |
| Date | Value |
|---|---|
| August 06, 2026 | 51.64 |
| August 05, 2026 | 52.45 |
| August 04, 2026 | 53.07 |
| August 03, 2026 | 49.57 |
| July 31, 2026 | 47.99 |
| July 30, 2026 | 48.44 |
| July 29, 2026 | 47.64 |
| July 28, 2026 | 47.55 |
| July 27, 2026 | 46.73 |
| July 24, 2026 | 46.54 |
| July 23, 2026 | 47.53 |
| July 22, 2026 | 47.24 |
| July 21, 2026 | 48.15 |
| July 20, 2026 | 46.99 |
| July 17, 2026 | 47.78 |
| July 16, 2026 | 48.57 |
| July 15, 2026 | 51.37 |
| July 14, 2026 | 50.46 |
| July 13, 2026 | 50.63 |
| July 10, 2026 | 53.35 |
| July 09, 2026 | 56.34 |
| July 08, 2026 | 59.20 |
| July 07, 2026 | 60.77 |
| July 06, 2026 | 61.89 |
| July 02, 2026 | 60.08 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Vertex Pharmaceuticals, Inc. | 515.44 |
| Basilea Pharmaceutica AG | 77.40 |
| Santhera Pharmaceuticals Holding AG | 19.79 |
| BeOne Medicines Ltd. | 346.51 |
| AC Immune SA | 2.76 |